Evaluation of a genetically modified reassortant H5N1 influenza a virus vaccine candidate generated by plasmid-based reverse genetics

Virology

Volumn 305, Issue 1, 2003, Pages 192-200

  Subbarao, Kanta ^a   Chen, Hualan ^a   Swayne, David ^b   Mingay, Louise ^c   Fodor, Ervin ^c   Brownlee, George ^c   Xu, Xiyan ^a   Lu, Xiuhua ^a   Katz, Jacqueline ^a   Cox, Nancy ^a   Matsuoka, Yumiko ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b AGRICULTURAL RESEARCH SERVICE   (United States)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

H5N1 vaccine; Pandemic influenza; Reverse genetics; Vaccines

Indexed keywords

INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; SIALIDASE;

ANIMAL MODEL; ANIMAL TISSUE; ANTIGENICITY; ARTICLE; CHICKEN; CONTROLLED STUDY; DNA MODIFICATION; DRUG EFFICACY; EMBRYO; GENETIC TRANSFECTION; GENOTYPE; HUMAN; HUMAN CELL; IMMUNOGENETICS; IMMUNOGENICITY; INFLUENZA; INFLUENZA VIRUS A; MOUSE; NONHUMAN; PATHOGENICITY; POULTRY; PRIORITY JOURNAL; PROTEIN MOTIF; PUERTO RICO; VIRUS STRAIN; VIRUS TRANSMISSION; WILD TYPE;

ANATIDAE; AVES; GALLUS GALLUS; INFLUENZA A VIRUS; INFLUENZA VIRUS;

EID: 0037227584     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2002.1742     Document Type: Article

References (46)

1. Bender, C., Hall, H., Huang, J., Klimov, A., Cox, N., Hay, A., Gregory, V., Cameron, K., Lim, W., and Subbarao, K. (1999). Characterization of the surface proteins of influenza A (H5N1) viruses isolated from humans in 1997-1998. Virology 254, 115-123.
2. Cauthen, A. N., Swayne, D. E., Schultz-Cherry, S., Perdue, M. L., and Suarez, D. L. (2000). Continued circulation in China of highly pathogenic avian influenza viruses encoding the hemagglutinin gene associated with the 1997 H5N1 outbreak in poultry and humans. J. Virol. 74, 6592-6599.
3. Chin, P. S., Hoffmann, E., Webby, R., Webster, R. G., Guan, Y., Peiris, M., and Shortridge, K. F. (2002). Molecular evolution of H6 influenza viruses from poultry in Southeastern China: Prevalence of H6N1 influenza viruses possessing seven A/Hong Kong/156/97 (H5N1)-like genes in poultry. J. Virol. 76, 507-516.
4. Claas, E. C., Osterhaus, A. D., van Beek, R., De Jong, J. C., Rimmelzwaan, G. F., Senne, D. A., Krauss, S., Shortridge, K. F., and Webster, R. G. (1998). Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet 351, 472-477.
5. DuBridge, R. B., Tang, P., Hsia, H. C., Leong, P.-M., Miller, J. H., and Calos, M. P. (1987). Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol. Cell. Biol. 7, 379-387.
6. Fodor, E., Devenish, L., Engelhardt, O. G., Palese, P., Brownlee, G. G., and Garcia-Sastre, A. (1999). Rescue of influenza A virus from recombinant DNA. J. Virol. 73, 9679-9682.
7. Garcia, M., Crawford, J. M., Latimer, J. W., Rivera-Cruz, E., and Perdue, M. L. (1996). Heterogeneity in the haemagglutinin gene and emergence of the highly pathogenic phenotype among recent H5N2 avian influenza viruses from Mexico. J. Gen. Virol. 77, 1493-1504.
8. Garcia-Sastre, A., and Palese, P. (1993). Genetic manipulation of negative-strand RNA virus genomes. [Review] Annu. Rev. Microbiol. 47, 765-790.
9. Guan, Y., Peiris, J. S. M., Lipatov, A. S., Ellis, T. M., Dyrting, K. C., Krauss, S., Zhang, L. J., Webster, R. G., and Shortridge, K. F. (2002). Emergence of multiple genotypes of H5N1 avian influenza viruses in Hong Kong SAR. Proc. Natl. Acad. Sci. USA 99, 8950-8955.
10. Guan, Y., Shortridge, K. F., Krauss, S., Chin, P. S., Dyrting, K. C., Ellis, T. M., Webster, R. G., and Peiris, M. (2000). H9N2 influenza viruses possessing H5N1-like internal genomes continue to circulate in poultry in southeastern China. J. Virol. 74, 9372-9380.
11. Guan, Y., Shortridge, K. F., Krauss, S., and Webster, R. G. (1999). Molecular characterization of H9N2 influenza viruses: Were they the donors of the "internal" genes of H5N1 viruses in Hong Kong? Proc. Natl. Acad. Sci. USA 96, 9363-9367.
12. Guo, Y. J., Li, J. W., Cheng, I., Wang, M., Zhou, Y., Li, X. H., Cai, F., Miao, H. L., Zhang, H., and Guo, F. (1999). Discovery of humans infected by avian influenza A (H9N2) virus. Chin. J. Exp. Clin. Virol. 15, 105-108.
13. Hatta, M., Gao, P., Halfmann, P., and Kawaoka, Y. (2001). Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science 293, 1840-1842.
14. Hoffmann, E., Stech, J., Leneva, I., Krauss, S., Scholtissek, C., Chin, P. S., Peiris, M., Shortridge, K. F., and Webster, R. G. (2000). Characterization of the influenza A virus gene pool in avian species in southern China: Was H6N1 a derivative or a precursor of H5N1? J. Virol. 74, 6309-6315.
15. Katz, J. M., Lu, X., Tumpey, T. M., Smith, C. B., Shaw, M. W., and Subbarao, K. (2000). Molecular correlates of influenza A H5N1 virus pathogenesis in mice. J. Virol. 74, 10807-10810.
16. Kilbourne, E. D. (1969). Future influenza vaccines and the use of genetic recombinants. Bull. World Health Organ. 41, 643-645.
17. Klenk, H. D., Rott, R., Orlich, M., and Blodorn, J. (1975). Activation of influenza A viruses by trypsin treatment. Virology 68, 426-439.
18. Kodihalli, S., Goto, H., Kobasa, D. L., Krauss, S., Kawaoka, Y., and Webster, R. G. (1999). DNA vaccine encoding hemagglutinin provides protective immunity against H5N1 influenza virus infection in mice. J. Virol. 73, 2094-2098.
19. Li, S., Liu, C., Klimov, A., Subbarao, K., Perdue, M. L., Mo, D., Ji, Y., Woods, L., Hietala, S., and Bryant, M. (1999). Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses. J. Infect. Dis. 179, 1132-1138.
20. Lin, Y. P., Shaw, M., Gregory, V., Cameron, K., Lim, W., Klimov, A., Subbarao, K., Guan, Y., Krauss, S., Shortridge, K., Webster, R., Cox, N., and Hay, A. (2000). Avian-to-human transmission of H9N2 subtype influenza A viruses: Relationship between H9N2 and H5N1 human isolates. Proc. Natl. Acad. Sci. USA 97, 9654-9658.
21. Lu, X., Tumpey, T. M., Morken, T., Zaki, S. R., Cox, N. J., and Katz, J. M. (1999). A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans. J. Virol. 73, 5903-5911.
22. Mounts, A. W., Kwong, H., Izurieta, H. S., Ho, Y., Au, T., Lee, M., Buxton Bridges, C., Williams, S. W., Mak, K. H., Katz, J. M., Thompson, W. W., Cox, N. J., and Fukuda, K. (1999). Case-control study of risk factors for avian influenza A (H5N1) disease, Hong Kong, 1997. J. Infect. Dis. 180, 505-508.
23. Neumann, G., Watanabe, T., Ito, H., Watanabe, S., Goto, H., Gao, P., Hughes, M., Perez, D. R., Donis, R., Hoffmann, E., Hobom, G., and Kawaoka, Y. (1999). Generation of influenza A viruses entirely from cloned cDNAs. Proc. Natl. Acad. Sci. USA 96, 9345-9350.
24. Nicholson, K. G., Colegate, A. E., Podda, A., Stephenson, I., Wood, J., Ypma, E., and Zambon, M. C. (2001). Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: A randomised trial of two potential vaccines against H5N1 influenza. Lancet 357, 1937-1943.
25. Peiris, M., Yuen, K. Y., Leung, C. W., Chan, K. H., Ip, P. L., Lai, R. W., Orr, W. K., and Shortridge, K. F. (1999). Human infection with influenza H9N2. Lancet 354, 916-917.
26. Perdue, M. L., Garcia, M., Senne, D. A., and Fraire, M. (1997). Virulence-associated sequence duplication at the hemagglutinin cleavage site of avian influenza viruses. Virus Res. 49, 173-186.
27. Reed, L. J., and Muench, H. (1938). A simple method of estimating fifty percent endpoints. Am. J. Hyg. 27, 493-497.
28. Richmond, J. Y., and McKinney, R. W. (1993). "Biosafety in Microbiological and Biomedical Laboratories." U.S. Department of Health and Human Services, CDC/NIH, Washington, D.C.
29. Rimmelzwaan, G. F., Claas, E. C. J., van Amerongen, G., de Jong, J. C., and Osterhaus, A. (1999). ISCOM vaccine induced protection against a lethal challenge with a human H5N1 influenza virus. Vaccine 17, 1355-1358.
30. Rowe, T., Abernathy, R. A., Hu-Primmer, J., Thompson, W. W., Lu, X., Lim, W., Fukuda, K., Cox, N. J., and Katz, J. M. (1999). Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J. Clin. Microbiol. 37, 937-943.
31. Schickli, J. H., Flandorfer, A., Nakaya, T., Martinez-Sobrido, L., Garcia-Sastre, A., and Palese, P. (2001). Plasmid-only rescue of influenza A virus vaccine candidates. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 356, 1965-1973.
32. Senne, D. A., Panigrahy, B., Kawaoka, Y., Pearson, J. E., Suss, J., Lipkind, M., Kida, H., and Webster, R. G. (1996). Survey of the hemagglutinin (HA) cleavage site sequence of H5 and H7 avian influenza viruses: Amino acid sequence at the HA cleavage site as a marker of pathogenicity potential. Avian Dis. 40, 425-437.
33. Shortridge, K. F. (1999). Poultry and the influenza H5N1 outbreak in Hong Kong, 1997: Abridged chronology and virus isolation. Vaccine 17 (Suppl. 1), S26-S29.
34. Shortridge, K. F., Butterfield, W. K., Webster, R. G., and Campbell, C. H. (1977). Isolation and characterization of influenza A viruses from avian species in Hong Kong. Bull. World Health Organ. 55, 15-20.
35. Shortridge, K. F., Zhou, N. N., Guan, Y., Gao, P., Ito, T., Kawaoka, Y., Kodihalli, S., Krauss, S., Markwell, D., Murti, K. G., Norwood, M., Senne, D., Sims, L., Takada, A., and Webster, R. G. (1998). Characterization of avian H5N1 influenza viruses from poultry in Hong Kong. Virology 252, 331-342.
36. Suarez, D. L., Perdue, M. L., Cox, N., Rowe, T., Bender, C., Huang, J., and Swayne, D. E. (1998). Comparisons of highly virulent H5N1 influenza A viruses isolated from humans and chickens from Hong Kong. J. Virol. 72, 6678-6688.
37. Subbarao, K., Klimov, A., Katz, J., Regnery, H., Lim, W., Hall, H., Perdue, M., Swayne, D., Bender, C., Huang, J., Hemphill, M., Rowe, T., Shaw, M., Xu, X., Fukuda, K., and Cox, N. (1998). Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science 279, 393-396.
38. Subbarao, K., and Shaw, M. W. (2000). Molecular aspects of avian influenza (H5N1) viruses isolated from humans. Rev. Med. Virol. 10, 337-348.
39. Takada, A., Kuboki, N., Okazaki, K., Ninomiya, A., Tanaka, H., Ozaki, H., Itamura, S., Nishimura, H., Enami, M., Tashiro, M., Shortridge, K. F., and Kida, H. (1999). Avirulent Avian influenza virus as a vaccine strain against a potential human pandemic. J. Virol. 73, 8303-8307.
40. Treanor, J. J., Wilkinson, B. E., Masseoud, F., Hu-Primmer, J., Battaglia, R., O'Brien, D., Wolff, M., Rabinovich, G., Blackwelder, W., and Katz, J. M. (2001). Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans. Vaccine 19, 1732-1737.
41. Tumpey, T. M., Renshaw, M., Clements, J. D., and Katz, J. M. (2001). Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection. J. Virol. 75, 5141-5150.
42. USAHA (1994). Proceedings of the 98th Annual Meeting U.S. Animal Health Association. U.S. Animal Health Association, Grand Rapids, MI.
43. Webster, R. G., Guan, Y., Peiris, M., Walker, D., Krauss, S., Zhou, N. N., Govorkova, E. A., Ellis, T. M., Dyrting, K. C., Sit, T., Perez, D. R., and Shortridge, K. F. (2002). Characterization of H5N1 influenza viruses that continue to circulate in geese in southeastern China. J. Virol. 76, 118-126.
44. Wood, J. M., Major, D., Daly, J., Newman, R. W., Dunleavy, U., Nicolson, C., Robertson, J. S., and Schild, G. C. (2000a). Vaccines against H5N1 influenza. Vaccine 18, 579-580.
45. Wood, J. M., Nicholson, K. G., Zambon, M., Hinton, R., Major, D. L., Newman, R. S., Dunleavy, U., Melzack, D., Robertson, J. S., and Schild, G. C. (2000b). Options for the Control of Influenza IV, Crete, Greece.
46. Xu, X. Y., Subbarao, K., Cox, N. J., and Guo, Y. J. (1999). Genetic characterization of the pathogenic influenza A/Goose/Guangdong/ 1/96 (H5N1) virus: Similarity of its hemagglutinin gene to those of H5N1 viruses from the 1997 outbreaks in Hong Kong. Virology 261, 15-19.